Experienced exercisers are often the ones who get rhabdo. Take Amy Wilkinson, who developed rhabdomyolysis symptoms after ...
New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-risk cutaneous squamous cell ...